These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19482053)

  • 1. Low-dose amisulpride induced Pisa syndrome in an alcohol-dependent patient with liver cirrhosis.
    Kuo SC; Yeh YW; Chen CY; Chen CL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1080-1. PubMed ID: 19482053
    [No Abstract]   [Full Text] [Related]  

  • 2. Pisa syndrome during amisulpride treatment.
    Li TC; Chiu HW; Liu HH
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352s.e27-352.e27. PubMed ID: 20686163
    [No Abstract]   [Full Text] [Related]  

  • 3. Tardive dystonia associated with low-dose of amisulpride: a case report.
    Sevincok L; Balci V; Akyildiz U
    J Clin Psychopharmacol; 2008 Oct; 28(5):573-4. PubMed ID: 18794659
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of γ-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: a case report.
    Caputo F; Bernardi M; Zoli G
    J Clin Psychopharmacol; 2011 Feb; 31(1):140-1. PubMed ID: 21192167
    [No Abstract]   [Full Text] [Related]  

  • 5. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 6. Amisulpride-induced dystonia.
    Das PP; Grover S; Sahoo M
    Aust N Z J Psychiatry; 2008 May; 42(5):430-1. PubMed ID: 18504810
    [No Abstract]   [Full Text] [Related]  

  • 7. Blockade of cue-induced brain activation of abstinent alcoholics by a single administration of amisulpride as measured with fMRI.
    Hermann D; Smolka MN; Wrase J; Klein S; Nikitopoulos J; Georgi A; Braus DF; Flor H; Mann K; Heinz A
    Alcohol Clin Exp Res; 2006 Aug; 30(8):1349-54. PubMed ID: 16899037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amisulpride-induced both oculogyric crisis and trismus.
    Mendhekar DN; Yajuvendra B; Aggarwal A
    Indian J Med Sci; 2008 Jun; 62(6):239-41. PubMed ID: 18603743
    [No Abstract]   [Full Text] [Related]  

  • 9. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A; Cazali J
    J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
    [No Abstract]   [Full Text] [Related]  

  • 10. Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial.
    Marra D; Warot D; Berlin I; Hispard E; Notides C; Tilikete S; Payan C; Lépine JP; Dally S; Aubin HJ
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1545-52. PubMed ID: 12394288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy.
    Peritogiannis V; Tsouli S; Pappas D; Mavreas V; Konitsiotis S
    Clin Neuropharmacol; 2007; 30(4):245-6. PubMed ID: 17762322
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperprolactinemia after low dose of amisulpride.
    Kopecek M; Bares M; Svarc J; Dockery C; Horácek J
    Neuro Endocrinol Lett; 2004 Dec; 25(6):419-22. PubMed ID: 15665803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
    Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
    J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: A population-based cohort study.
    Linderoth G; Jepsen P; Schønheyder HC; Johnsen SP; Sørensen HT
    Alcohol Clin Exp Res; 2006 Apr; 30(4):636-41. PubMed ID: 16573581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulpiride-induced tardive dystonia.
    Miller LG; Jankovic J
    Mov Disord; 1990; 5(1):83-4. PubMed ID: 1967484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.
    Pelletier G; Roulot D; Davion T; Masliah C; Causse X; Oberti F; Raabe JJ; Van Lemmens C; Labadie H; Serfaty L;
    Hepatology; 2003 Apr; 37(4):887-92. PubMed ID: 12668982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
    Müller MJ; Eich FX; Regenbogen B; Sachse J; Härtter S; Hiemke C
    J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic bradycardia associated with amisulpride.
    Pedrosa Gil F; Grohmann R; Rüther E
    Pharmacopsychiatry; 2001 Nov; 34(6):259-61. PubMed ID: 11778148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic fibrosis in patients with alcoholic dependence syndrome.
    Suda K; Akai J; Nakamura T
    Arch Pathol Lab Med; 1993 Oct; 117(10):1013-6. PubMed ID: 8215822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.